Long noncoding RNAs (CTC-471J1.2, NeST) as epigenetic risk factors of active juvenile lupus nephritis: a case-control study

Pediatr Rheumatol Online J. 2024 Apr 27;22(1):48. doi: 10.1186/s12969-023-00945-1.

Abstract

Background: Measurement of the circulating levels of long-non-coding RNAs (lncRNAs) in lupus nephritis (LN) patients could dramatically explore more insights about the disease pathogenesis. Hence, we aimed to quantify the level of expression of CTC-471J1.2 and NeST in LN patients and to correlate it with the disease activity.

Method: This case-control study was conducted on a group of children with juvenile LN attending to Mansoura University Children's Hospital (MUCH). Demographics, clinical, and laboratory findings were collected besides the measurement of lncRNAs by quantitative real-time PCR.

Results: The expression level of lncRNAs-CTC-471J1.2 was significantly down-regulated in children with active LN versus inactive cases or controls. In contrast, the NeST was significantly up-regulated in active LN cases. A significant correlation was found between CTC-471J1.2 expression and LN activity parameters. Additionally, both lncRNAs showed a reasonable sensitivity and specificity in differentiation of active LN. A regression analysis model revealed that CTC-471J1.2 and NeST were independent predictors of active nephritis.

Conclusion: The expression level of circulatory lncRNAs-CTC-471J1.2 and NeST can be used as sensitive and specific biomarkers for active LN. Furthermore, both could serve as predictors for nephritis activity.

Keywords: NeST; CTC-471J1.2; Long-non-coding RNA; Lupus nephritis.

MeSH terms

  • Adolescent
  • Biomarkers / blood
  • Biomarkers / metabolism
  • Case-Control Studies
  • Child
  • Epigenesis, Genetic
  • Female
  • Humans
  • Lupus Nephritis* / blood
  • Lupus Nephritis* / genetics
  • Male
  • RNA, Long Noncoding* / blood
  • RNA, Long Noncoding* / genetics
  • Risk Factors

Substances

  • RNA, Long Noncoding
  • Biomarkers